BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18003666)

  • 21. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
    Lonn E; Held C; Arnold JM; Probstfield J; McQueen M; Micks M; Pogue J; Sheridan P; Bosch J; Genest J; Yusuf S;
    Can J Cardiol; 2006 Jan; 22(1):47-53. PubMed ID: 16450017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled trial of homocysteine lowering and cognitive performance.
    McMahon JA; Green TJ; Skeaff CM; Knight RG; Mann JI; Williams SM
    N Engl J Med; 2006 Jun; 354(26):2764-72. PubMed ID: 16807413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
    Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
    J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
    JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
    Woolf K; Manore MM
    J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.
    Zoungas S; McGrath BP; Branley P; Kerr PG; Muske C; Wolfe R; Atkins RC; Nicholls K; Fraenkel M; Hutchison BG; Walker R; McNeil JJ
    J Am Coll Cardiol; 2006 Mar; 47(6):1108-16. PubMed ID: 16545638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
    Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM
    Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double-blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke.
    Liu X; Shi M; Xia F; Han J; Liu Z; Wang B; Yang F; Li L; Wu S; Wang L; Liu N; Lv Y; Zhao G
    Int J Stroke; 2015 Feb; 10(2):264-8. PubMed ID: 23490255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy.
    Lewerin C; Jacobsson S; Lindstedt G; Nilsson-Ehle H
    Scand J Gastroenterol; 2008; 43(9):1050-6. PubMed ID: 18609169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.
    Van Guelpen B; Hultdin J; Johansson I; Witthöft C; Weinehall L; Eliasson M; Hallmans G; Palmqvist R; Jansson JH; Winkvist A
    J Intern Med; 2009 Aug; 266(2):182-95. PubMed ID: 19298497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
    Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
    Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases.
    Horvath B; Szapary L; Debreceni L; Feher G; Kenyeres P; Fulop A; Battyani I; Toth K
    Clin Hemorheol Microcirc; 2009; 42(1):19-28. PubMed ID: 19363237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
    Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.
    Ebbing M; Bønaa KH; Arnesen E; Ueland PM; Nordrehaug JE; Rasmussen K; Njølstad I; Nilsen DW; Refsum H; Tverdal A; Vollset SE; Schirmer H; Bleie Ø; Steigen T; Midttun Ø; Fredriksen A; Pedersen ER; Nygård O
    J Intern Med; 2010 Oct; 268(4):367-82. PubMed ID: 20698927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamins and stroke: the homocysteine hypothesis still in doubt.
    Ntaios GC; Savopoulos CG; Chatzinikolaou AC; Kaiafa GD; Hatzitolios A
    Neurologist; 2008 Jan; 14(1):2-4. PubMed ID: 18195649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of plasma homocysteine by folic acid in children with chronic renal failure.
    Kang HG; Lee BS; Hahn H; Lee JH; Ha IS; Cheong HI; Choi Y
    Pediatr Nephrol; 2002 Jul; 17(7):511-4. PubMed ID: 12172764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure].
    Kozłowska I
    Ann Acad Med Stetin; 2004; 50(1):87-95. PubMed ID: 16871747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients.
    Sun Y; Lu CJ; Chien KL; Chen ST; Chen RC
    Clin Ther; 2007 Oct; 29(10):2204-14. PubMed ID: 18042476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.